Cantitate/Preț
Produs

Obesity, Fatty Liver and Liver Cancer: Advances in Experimental Medicine and Biology, cartea 1061

Editat de Jun Yu
en Limba Engleză Hardback – 12 iul 2018
This volume covers a state-of-the-art illustration of recent discoveries concerning obesity-related fatty liver diseases and liver cancer. The contents are extensive and comprehensive. It brings important topics in the field all together under one umbrella, from epidemiology and etiology, molecular pathogenesis, cellular biology, epigenetics, immunology, microbiology, animal models to therapeutic approaches and treatments. All the book contributors are leading experts in the field. It will appeal to researchers, clinicians and graduate students in obesity, fatty liver diseases, GI/Liver cancer field. It may also yield benefits for pharmaceutical companies with regard to drug discovery.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 97205 lei  38-44 zile
  Springer Nature Singapore – 6 feb 2019 97205 lei  38-44 zile
Hardback (1) 106033 lei  3-5 săpt.
  Springer Nature Singapore – 12 iul 2018 106033 lei  3-5 săpt.

Din seria Advances in Experimental Medicine and Biology

Preț: 106033 lei

Preț vechi: 111614 lei
-5% Nou

Puncte Express: 1590

Preț estimativ în valută:
20291 21436$ 16964£

Carte disponibilă

Livrare economică 11-25 decembrie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9789811086830
ISBN-10: 9811086834
Pagini: 363
Ilustrații: XII, 157 p. 24 illus., 23 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 0.61 kg
Ediția:1st ed. 2018
Editura: Springer Nature Singapore
Colecția Springer
Seria Advances in Experimental Medicine and Biology

Locul publicării:Singapore, Singapore

Cuprins

Chapter 1. Introduction.- Chapter 2. Epidemiology and etiology of NAFLD and associated HCC.- Chapter 3. Pathogenesis of NASH: How metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease.- Chapter 4. Chemokines and Chemokine Receptors in the Development of NAFLD.- Chapter 5. NAFLD related-HCC: the relationship with metabolic disorders.- Chapter 6. Hepatocellular carcinoma in obesity: Finding a needle in the haystack?.- Chapter 7. Dysregulated epigenetic modifications in the pathogenesis of NAFLD-HCC.- Chapter 8. The Influence of Gut Microbial Metabolism on the Development and Progression of Non-alcoholic Fatty Liver Disease.- Chapter 9. Microbiota, obesity and NAFLD.- Chapter 10. Autophagy, NAFLD and NAFLD-related HCC.- Chapter 11. Animal models of non-alcoholic fatty liver diseases and its associated liver cancer.- Chapter 12. Current prevention and treatment options for NAFLD.

Notă biografică

Prof. Jun Yu is Professor in Department of Medicine & Therapeutics, Director of Research Laboratory of Institute of Digestive Disease, Associate Director of State Key Laboratory of Digestive Disease and Faculty of Medicine in The Chinese University of Hong Kong.

Textul de pe ultima copertă

This volume covers a state-of-the-art illustration of recent discoveries concerning obesity-related fatty liver diseases and liver cancer. The contents are extensive and comprehensive. It brings important topics in the field all together under one umbrella, from epidemiology and etiology, molecular pathogenesis, cellular biology, epigenetics, immunology, microbiology, animal models to therapeutic approaches and treatments. All the book contributors are leading experts in the field. It will appeal to researchers, clinicians and graduate students in obesity, fatty liver diseases, GI/Liver cancer field. It may also yield benefits for pharmaceutical companies with regard to drug discovery.

Caracteristici

Covers a state-of-the-art illustration of recent discoveries concerning obesity-related fatty liver diseases and liver cancer Brings important topics in the field all together under one umbrella Provides an extensive and comprehensive material for the researchers, clinicians and students in fatty liver diseases, GI/Liver cancer field